Plain-English translation of NCT06325800 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
The GlycOxiTOD study is an observational registry that follows adults with high blood pressure or increased risk for heart disease. Researchers collect medical records, imaging scans, blood work, and other health information to understand how blood vessels and organs become damaged before someone has a heart attack or stroke. This study does not assign any medications or change your regular medical care—your doctor makes all treatment decisions.
Many people develop early damage to their blood vessels and organs due to high blood pressure, diabetes, or other conditions, but this damage may not be obvious with standard tests. This research aims to identify these hidden changes and understand the biological processes that cause them, so doctors can better predict and prevent serious heart disease in the future.
You likely qualify if…
You likely don't qualify if…
If you join, you will visit the study center for cardiovascular assessment, which may include blood pressure measurements, blood tests, imaging scans (like ultrasound of your arteries), and special optical sensors that measure blood flow in your fingertip. Your medical records will be reviewed, and you may be followed over time through additional visits or medical record checks to see how your cardiovascular health changes. The study does not require you to take any new medications or change your usual care.
AI-generated summary from trial data · Sep 17, 2026 · Not medical advice
Spain